A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo
Clinical trial NCT03333538 · COMPLETED
Trial details
- NCT number
- NCT03333538
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-03
- Primary completion
- 2018-11-30
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.